Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Rectal Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 125S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Radiotherapy 97Paclitaxel 97Bevacizumab 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54toripalimab 53Sorafenib 53Folfox protocol 53Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × ferumoxtran-10 × Gastrointestinal × Clear all
NCT02751606 2018-12-06

Nano MRI on 7 Tesla in Rectal and Breast Cancer

Radboud University Medical Center

Phase 3 Unknown
30 enrolled
BreastGastrointestinal

Breast Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡